Oncimmune Historical Income Statement
| ONC Stock | 14.75 0.05 0.34% |
Historical analysis of Oncimmune Holdings income statement accounts such as Total Revenue of 1.4 M can show how well Oncimmune Holdings plc performed in making a profits. Evaluating Oncimmune Holdings income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Oncimmune Holdings's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Oncimmune Holdings plc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Oncimmune Holdings plc is a good buy for the upcoming year.
Oncimmune |
About Oncimmune Income Statement Analysis
Oncimmune Holdings plc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Oncimmune Holdings shareholders. The income statement also shows Oncimmune investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Oncimmune Holdings Income Statement Chart
Add Fundamental
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Most accounts from Oncimmune Holdings' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Oncimmune Holdings plc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncimmune Holdings plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At present, Oncimmune Holdings' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 1.4 M, whereas Gross Profit is forecasted to decline to about 716.4 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 943K | 2.0M | 2.3M | 2.4M | Depreciation And Amortization | 197K | 981K | 1.1M | 1.2M |
Oncimmune Holdings income statement Correlations
Click cells to compare fundamentals
Oncimmune Holdings Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Oncimmune Holdings income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 500K | 740K | 197K | 981K | 1.1M | 1.2M | |
| Interest Expense | 626K | 954K | 943K | 2.0M | 2.3M | 2.4M | |
| Selling General Administrative | 8.2M | 5.7M | 7.1M | 434K | 499.1K | 474.1K | |
| Total Revenue | 509K | 3.7M | 3.9M | 1.2M | 1.3M | 1.4M | |
| Gross Profit | (28K) | 2.9M | 1.5M | 792K | 910.8K | 716.4K | |
| Other Operating Expenses | 10.4M | 8.9M | 12.4M | 5.4M | 6.2M | 7.5M | |
| Operating Income | (9.3M) | (5.1M) | (8.6M) | (4.2M) | (3.8M) | (4.0M) | |
| Ebit | (9.5M) | (5.2M) | (7.4M) | (5.4M) | (4.9M) | (5.1M) | |
| Research Development | 1.7M | 1.6M | 1.5M | 1.3M | 1.4M | 1.3M | |
| Ebitda | (9.0M) | (4.5M) | (7.2M) | (4.4M) | (4.0M) | (4.2M) | |
| Cost Of Revenue | 537K | 865K | 2.4M | 360K | 414K | 707.1K | |
| Total Operating Expenses | 9.8M | 8.0M | 10.0M | 5.0M | 5.8M | 6.8M | |
| Income Before Tax | (9.8M) | (5.7M) | (9.5M) | (5.9M) | (5.3M) | (5.6M) | |
| Total Other Income Expense Net | (515K) | (551K) | (943K) | (1.7M) | (1.5M) | (1.4M) | |
| Net Income | (8.5M) | (4.6M) | (9.5M) | 4.1M | 3.7M | 3.9M | |
| Income Tax Expense | (1.3M) | (1.1M) | (17K) | 223K | 200.7K | 210.7K | |
| Net Income From Continuing Ops | (8.5M) | (4.6M) | (9.5M) | (6.2M) | (5.5M) | (5.8M) | |
| Net Income Applicable To Common Shares | (8.0M) | (8.5M) | (4.6M) | (9.5M) | (8.6M) | (9.0M) | |
| Tax Provision | (1.3M) | (1.1M) | (17K) | 223K | 256.5K | 269.3K | |
| Net Interest Income | (515K) | (551K) | (943K) | (1.8M) | (1.6M) | (1.5M) | |
| Reconciled Depreciation | 500K | 740K | 1.4M | 981K | 1.1M | 653.7K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Oncimmune Stock
Oncimmune Holdings plc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Oncimmune Holdings shareholders. The income statement also shows Oncimmune investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).